Evidence map›Paper›PMID 41442757›Full record

ArticleThe journals of gerontology. Series B, Psychological sciences and social sciences2025

Clinical and environmental factors, functional status, and multimorbidity-stratifying progression and prognosis of multimorbidity, frailty, and disability: the Age-It Research Program.

Licia Iacoviello, Rosa Liperoti, Patrizia Rovere Querini, Stefano Salvioli, Pasquale Abete, Massimiliano Fedecostante, Fabrizia Lattanzio, Antonio Cherubini

Abstract read
In one paragraph

Article in The journals of gerontology. Series B, Psychological sciences and social sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Aging well in an aging society: Italy at the forefront of global aging and the Age-It Research Program.The journals of gerontology. Series B, Psychological sciences and social sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Licia IacovielloDepartment of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy.ORCID 0000-0003-0514-5885
Rosa LiperotiFondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.ORCID 0000-0003-3740-1687
Patrizia Rovere QueriniInternal Medicine Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0003-2615-3649
Stefano SalvioliDepartment of Medical and Surgical Science (DIMEC), University of Bologna, Bologna, Italy.
Pasquale AbeteDepartment of Translational Medical Sciences, Federico II University, Naples, Italy.
Massimiliano FedecostanteGeriatria, Accettazione Geriatrica e Centro di Ricerca per l'Invecchiamento, IRCCS INRCA, Ancona, Italy.ORCID 0000-0002-0130-5805
Fabrizia LattanzioScientific Direction, IRCCS INRCA, Ancona, Italy.ORCID 0000-0003-4051-1289
Antonio CherubiniGeriatria, Accettazione Geriatrica e Centro di Ricerca per l'Invecchiamento, IRCCS INRCA, Ancona, Italy.ORCID 0000-0003-0261-9897

Funding

Age-It-Ageing well in an ageing society CUP B13D22001320006Age-It-Ageing well in an ageing society PE0000015European CommissionEuropean UnionNational Recovery and Resilience PlanNext Generation EU
6 · The paper itself

Abstract

objectivesThis paper describes the methodology and activities of the third thematic challenge (Spoke 3) of the Age-It program. Spoke 3 aims to address the clinical complexity and heterogeneity of older subjects' phenotypes through an interdisciplinary biomedical approach.

methodsSpoke 3 will investigate biomarkers related to multimorbidity and frailty, develop prognostic algorithms using novel methodological approaches, including artificial intelligence (AI) techniques to combine biological and clinical data, and identify management strategies for complex older subjects with multimorbidity and frailty. These activities will be realized by launching new prospective longitudinal studies and through new analyses of existing longitudinal cohorts.

resultsSpoke 3 is expected to generate original evidence concerning older subjects with multimorbidity and/or frailty, to support a more precise diagnostic evaluation, to improve the ability to predict the functional and cognitive trajectories, with the final aim of better managing this complex population. Spoke 3 also aims to evaluate the impact of climate change and pollution on the health status of older subjects by combining health and environmental data. DISCUSSION: Overcoming the traditional medical approach, focused on the diagnosis and treatment of single diseases, Spoke 3 should provide important original evidence to improve the management of older subjects with multimorbidity and frailty.

Indexed as

Frail ElderlyFrailtyFunctional StatusMultimorbidityPersons with DisabilitiesAgedAged, 80 and overArtificial IntelligenceDisease ProgressionGeriatric AssessmentHumansLongitudinal StudiesPrognosisArtificial intelligenceBiomarkers of ageFunctional health statusHealth outcomes

Identifiers

PMID41442757
PMCPMC12737001

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.